Ligne de temps

Fabien Le Chevalier
Post-doctorant(e)
07 sept. 2023
publication

Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Lire plus
18 avr. 2023
publication

Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication.

Lire plus
21 déc. 2022
publication

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters

Lire plus
27 avr. 2022
publication

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

Lire plus
29 juil. 2021
team

Laboratoire Commun Pasteur – TheraVectys

Lire plus
24 avr. 2018
publication

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors

Lire plus
17 janv. 2018
publication

Identification of genes required for Mycobacterium abscessus growth in vivo with a prominent role of the ESX-4 locus

Lire plus
15 janv. 2018
publication

Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosis

Lire plus
17 mai 2017
publication

PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis.

Lire plus
27 janv. 2016
publication

pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence

Lire plus
25 nov. 2015
publication

Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis

Lire plus
27 mai 2015
publication

Shaping mycolactone for therapeutic use against inflammatory disorders.

Lire plus
11 mai 2015
team

Pathogénomique Mycobactérienne Intégrée

Lire plus
08 déc. 2014
publication

Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice

Lire plus